标题：CR Sanjiu Medical & PharmaceuticalMain business growth stable expansion next
发布日期：2016-03-11 12:55:52
内容： Valuation and recommendation The stock is trading at 17x 2015, 16x 2016e and 15x 2017e P/E. Maintain BUY and TP at Rmb30 (23x 2016e P/E). Risks More competition in OTC market; lower medicine prices; adverse reactions from TCM injections; price hike for TCM raw materials.
发布日期：2016-03-11 12:55:52
内容： Valuation and recommendation The stock is trading at 17x 2015, 16x 2016e and 15x 2017e P/E. Maintain BUY and TP at Rmb30 (23x 2016e P/E). Risks More competition in OTC market; lower medicine prices; adverse reactions from TCM injections; price hike for TCM raw materials.
